User menu

Iron overload in children undergoing cancer treatments

Bibliographic reference de Ville de Goyet, Maêlle ; Moniotte, Stéphane ; Robert, Annie ; Dupont, Sophie ; Vermylen, Christiane ; et. al. Iron overload in children undergoing cancer treatments. In: Pediatric Blood & Cancer, Vol. 60, no. 12, p. 1982-1987 (2013)
Permanent URL http://hdl.handle.net/2078.1/134839
  1. Kohgo Yutaka, Ikuta Katsuya, Ohtake Takaaki, Torimoto Yoshihiro, Kato Junji, Body iron metabolism and pathophysiology of iron overload, 10.1007/s12185-008-0120-5
  2. Vermylen Christiane, What is new in iron overload?, 10.1007/s00431-007-0604-y
  3. Taher AT Mussalam KM Inati A Iron overload: Consequences, assessment, and monitoring
  4. Kaltwasser J.P., Werner E., 6 Diagnosis and clinical evaluation of iron overload, 10.1016/s0950-3536(89)80022-8
  5. Sirlin Claude B., Reeder Scott B., Magnetic Resonance Imaging Quantification of Liver Iron, 10.1016/j.mric.2010.08.014
  6. Anderson Lisa J., Assessment of Iron Overload with T2* Magnetic Resonance Imaging, 10.1016/j.pcad.2011.07.004
  7. Anderson L, Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload, 10.1053/euhj.2001.2822
  8. Carpenter J.-P., He T., Kirk P., Roughton M., Anderson L. J., de Noronha S. V., Sheppard M. N., Porter J. B., Walker J. M., Wood J. C., Galanello R., Forni G., Catani G., Matta G., Fucharoen S., Fleming A., House M. J., Black G., Firmin D. N., St. Pierre T. G., Pennell D. J., On T2* Magnetic Resonance and Cardiac Iron, 10.1161/circulationaha.110.007641
  9. Tziomalos Konstantinos, Liver iron content determination by magnetic resonance imaging, 10.3748/wjg.v16.i13.1587
  10. St. Pierre T. G., Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance, 10.1182/blood-2004-01-0177
  11. Wood J. C., MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients, 10.1182/blood-2004-10-3982
  12. Mulrooney D. A, Yeazel M. W, Kawashima T., Mertens A. C, Mitby P., Stovall M., Donaldson S. S, Green D. M, Sklar C. A, Robison L. L, Leisenring W. M, Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort, 10.1136/bmj.b4606
  13. Armstrong Gregory T., Liu Qi, Yasui Yutaka, Neglia Joseph P., Leisenring Wendy, Robison Leslie L., Mertens Ann C., Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor Study, 10.1200/jco.2008.21.1425
  14. Lipshultz S. E, Alvarez J. A, Scully R. E, Anthracycline associated cardiotoxicity in survivors of childhood cancer, 10.1136/hrt.2007.136093
  15. de Ville de Goyet Maëlle, Moniotte Stéphane, Brichard Bénédicte, Cardiotoxicity of Childhood Cancer Treatment: Update and Current Knowledge on Long-term Follow-up, 10.3109/08880018.2012.694092
  16. Shankar S. M., Marina N., Hudson M. M., Hodgson D. C., Adams M. J., Landier W., Bhatia S., Meeske K., Chen M. H., Kinahan K. E., Steinberger J., Rosenthal D., Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group, 10.1542/peds.2007-0575
  17. Mulder Renée L, van Dalen Elvira C, Van den Hof Malon, Leclercq Edith, Bresters Dorine, Koot Bart GP, Castellino Sharon M, Loke Yoon, Post Piet N, Caron Huib N, Postma Aleida, Kremer Leontien CM, Hepatic late adverse effects after antineoplastic treatment for childhood cancer, 10.1002/14651858.cd008205.pub2
  18. Mulder Renée L., Kremer Leontien C.M., Koot Bart G.P., Benninga Marc A., Knijnenburg Sebastiaan L., van der Pal Helena J.H., Koning Caro C.E., Oldenburger Foppe, Wilde James C.H., Taminiau Jan A.J.M., Caron Huib N., van Dalen Elvira C., Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: Prevalence and risk factors, 10.1016/j.ejca.2012.07.009
  19. Vag Tibor, Kentouche Karim, Krumbein Ines, Reichenbach Jürgen R., Lopatta Eric, Renz Diane M., Stenzel Martin, Beck James, Kaiser Werner A., Mentzel Hans-Joachim, Noninvasive measurement of liver iron concentration at MRI in children with acute leukemia: initial results, 10.1007/s00247-011-2122-3
  20. Reddy, Pediatr Blood Cancer, 56, 908 (2011)
  21. Kazak Anne E., Hocking Matthew C., Ittenbach Richard F., Meadows Anna T., Hobbie Wendy, DeRosa Branlyn Werba, Leahey Ann, Kersun Leslie, Reilly Anne, A revision of the intensity of treatment rating scale: Classifying the intensity of pediatric cancer treatment, 10.1002/pbc.23320
  22. Lorenz Christine, Walker Eloisa, Morgan Victoria, Klein Stacy, Graham Thomas, Normal Human Right and Left Ventricular Mass, Systolic Function, and Gender Differences by Cine Magnetic Resonance Imaging, 10.3109/10976649909080829
  23. Buechel Emanuela, Kaiser Thomas, Jackson Clare, Schmitz Achim, Kellenberger Christian J, Normal right- and left ventricular volumes and myocardial mass in children measured by steady state free precession cardiovascular magnetic resonance, 10.1186/1532-429x-11-19
  24. Ruccione Kathleen S., Mudambi Kiran, Sposto Richard, Fridey Joy, Ghazarossian Suzy, Freyer David R., Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors, 10.1002/pbc.24046
  25. Eng Jennifer, Fish Jonathan D., Insidious iron burden in pediatric patients with acute lymphoblastic leukemia, 10.1002/pbc.22851
  26. McDonald, West J Med, 140, 250 (1984)
  27. Castellino, Pediatr Blood Cancer, 54, 663 (2010)
  28. McKay, Bone Marrow Transplant, 17, 63 (1996)
  29. Chotsampancharoen Thirachit, Gan Kwan, Kasow Kimberly A., Barfield Raymond C., Hale Gregory A., Leung Wing, Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation, 10.1111/j.1399-3046.2008.00983.x
  30. Halonen Päivi, Mattila Jorma, Ruuska Tarja, Salo Matti K., Mäkipernaa Anne, Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings : Liver Changes After ALL Therapy, 10.1002/mpo.10231
  31. Halonen P., Mattila J., Suominen P., Ruuska T., Salo M. K., Makipernaa A., Iron Overload in Children Who Are Treated for Acute Lymphoblastic Leukemia Estimated by Liver Siderosis and Serum Iron Parameters, 10.1542/peds.111.1.91
  32. Noetzli L. J., Papudesi J., Coates T. D., Wood J. C., Pancreatic iron loading predicts cardiac iron loading in thalassemia major, 10.1182/blood-2009-06-225615
  33. Lee Duk-Hee, Jacobs David R, Serum markers of stored body iron are not appropriate markers of health effects of iron: a focus on serum ferritin, 10.1016/s0306-9877(03)00344-x
  34. Pakbaz Zahra, Fischer Roland, Fung Ellen, Nielsen Peter, Harmatz Paul, Vichinsky Elliott, Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients, 10.1002/pbc.21275
  35. Adamkiewicz T. V., Abboud M. R., Paley C., Olivieri N., Kirby-Allen M., Vichinsky E., Casella J. F., Alvarez O. A., Barredo J. C., Lee M. T., Iyer R. V., Kutlar A., McKie K. M., McKie V., Odo N., Gee B., Kwiatkowski J. L., Woods G. M., Coates T., Wang W., Adams R. J., Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury, 10.1182/blood-2009-02-203323
  36. Szőke Dominika, Panteghini Mauro, Diagnostic value of transferrin, 10.1016/j.cca.2012.04.021
  37. Au W.Y., Lam W.M., Chu W.C., Tam S., Wong W.K., Pennell D.J., Lie A.K., Liang R., A Magnetic Resonance Imaging Study of Iron Overload in Hemopoietic Stem Cell Transplant Recipients With Increased Ferritin Levels, 10.1016/j.transproceed.2007.09.027
  38. Leung Alex Wing Kwan, Chu Winnie Chiu Wing, Lam Wynnie Wai Man, Lee Vincent, Li Chi Kong, Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients, 10.1002/pbc.22170
  39. Schulz K. F, Altman D. G, Moher D., , CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials, 10.1136/bmj.c332